Discrimination between peptide and non-peptide opioid agonists on the transcription of opioid receptors in two cell lines

Life Sciences

Volumn 68, Issue 24, 2001, Pages 2731-2740

  Wang, Yun ^a   Wang, Xiao Min ^a   Han, Ji Sheng ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Gene expression; Long term exposure; Non peptide opioid agonist; Opioid receptor; Peptide opioid agonist

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; BETA ACTIN; BETA HYDROXYMEFENTANYL; COMPLEMENTARY DNA; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MESSENGER RNA; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BENZAMIDES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; FENTANYL; PIPERAZINES; POLYMERASE CHAIN REACTION; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0035805212     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01075-X     Document Type: Article

References (20)

1. Law PY, Hom DS, Loh HH. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol Pharmacol. 1983; 24(3): 413-24.
2. Tao PL, Lee HY, Chang LR, Loh HH. Decrease in mu-opioid receptor binding capacity in rat brain after chronic PL017 treatment. Brain Res. 1990 3; 526 (2): 270-5.
3. Raynor K, Kong H, Hines J, Kong G, Benovic J, Yasuda K, Bell GI, Reisine T. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor. J Pharmacol Exp Ther. 1994; 270(3):1381-6.
4. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science. 1992; 258 (5090): 1952-5.
5. Chen Y, Mestek A, Liu J, Yu L. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J. 1993;295 (Pt 3): 625-8.
6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem. 1987 162(1): 156-9.
7. Hirasawa A, Hashimoto K, Tsujimoto G. Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats. Eur J Pharmacol. 1994; 267(1): 71-5.
8. Markewitz BA, Michael JR, Kohan DE. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J Clin Invest. 1993; 91(5): 2138-43.
9. 5]enkephalin on rat brain opioid receptors. Eur J Pharmacol. 1991; 201(2-3): 209-14.
10. Zadina JE, Kastin AJ, Gel J, Chang SL. Novel peptides and mechanisms of opiate tolerance. Regul Pept. 1994; 54 (Suppl): S195-6.
11. Harrison LM, Kastin AJ, Zadina JE. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SHSY5Y human neuroblastoma cells. J Pharmacol Exp Ther. 1998; 284 (2):611-7.
12. Kim DS, Chin H, Klee WA. Agonist regulation of the expression of the delta opioid receptor in NG108-15 cells. FEBS Lett. 1995; 376(1-2):11-4.
13. Yeh GC, Chou WM, Lue TL, Wang TL and Tao PL. Tolerance to (D-A1a2, D-Leu5) enkephalin induces an alteration in transcripting the DOR-1. Regul Pept. 54 (Suppl): S335-336.
14. Sehba F, Duttaroy A, Shah S, Chen B, Carroll J, Yoburn BC. In vivo homologous regulation of mu-opioid receptor gene expression in the mouse. Eur J Pharmacol. 1997; 339 (1): 33-41.
15. Buzas B, Rosenberger J, Cox BM. Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport. 1996; 7(9):1505-8.
16. Von Zastrow M, Keith DE Jr, Evans CJ. Agonist-induced state of the delta-opioid receptor that discriminates between opioid peptides and opiate alkaloids. Mol Pharmacol. 1993; 44(1):166-72.
17. Miller KK, Lupica CR. Morphine-induced excitation of pyramidal neurons is inhibited by cholecystokinin in the CA1 region of the rat hippocampal slice. J Pharmacol Exp Ther. 1994;268 (2):753-61.
18. Gether U, Johansen TE, Snider RM, Lowe JA 3rd, Nakanishi S, Schwartz TW. Different binding epitopes on the NK1 receptor for substance P and non-peptide antagonist. Nature. 1993;362 (6418):345-8.
19. Beinborn M, Lee YM, McBride EW, Quinn SM, Kopin AS. A single amino acid of the cholecystokinin-B/ gastrin receptor determines specificity for non-peptide antagonists. Nature. 1993;362 (6418):348-50.
20. Xue JC, Chen C, Zhu J, Kunapuli S, DeRiel JK, Yu L, Liu-Chen LY. Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. J Biol Chem. 1994;269 (48):30195-9.